Citation Information :
Saha R, Pattanayak P, Datta K, Samanta M. A Challenging Case of Neuropsychiatric Juvenile-onset Systemic Lupus Erythematosus: Case Report. J Acad Pediatr Neurol 2025; 1 (1):25-27.
The involvement of the nervous system in systemic lupus erythematosus (SLE) patients leads to a nonspecific and heterogeneous group of neuropsychiatric (NP) manifestations. No laboratory or radiological biomarker nor other formal system exists for setting up a diagnosis and guiding therapy decisions in neuropsychiatric SLE (NPSLE). In clinical practice, an individual multidisciplinary diagnostic and therapeutic approach based on the suspected cause and severity of symptoms is recommended. We are reporting a case of NP juvenile-onset systemic lupus erythematosus which presented like a case of meningoencephalitis with unilateral hemiplegia.
Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011;365(22):2110–2121. DOI: 10.1056/NEJMra1100359.
Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: Pathogenesis and biomarkers. Nat Rev Neurol 2014;10(10):579–596. DOI: 10.1038/nrneurol.2014.148.
Zirkzee EJ, Steup-Beekman GM, van der Mast RC, et al. Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus. multidisciplinary approach to diagnosis and therapy. J Rheumatol 2012;39(11):2118–2126. DOI: 10.3899/jrheum.120545.
Borowoy AM, Pope JE, Silverman E, et al. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results fromthe 1000 faces of lupus cohort. Semin Arthritis Rheum 2012;42(2):179–185. DOI: 10.1016/j.semarthrit.2012.03.011.
Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074–2082. DOI: 10.1136/ard.2010.130476.
Mok CC, Lau CS, Wong RW. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study. Am J Med 2003;115(1):59–62. DOI: 10.1016/s0002-9343(03)00135-9.
Neuwelt CM, Lacks S, Kaye BR, et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 1995;98(1):32–41. DOI: 10.1016/S0002-9343(99)80078-3.
Ramos PC, Mendez MJ, Ames PR, et al. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol 1996;14(3):295–299. PMID: 8809444.
Stojanovich L, Stojanovich R, Kostich V, et al. Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study). Lupus 2003;12(1):3–7. DOI: 10.1191/0961203303lu251oa.